Bangalore (Karnataka) [India], October 18: In a world where managing calorie intake is a paramount concern for health-conscious consumers, Teestar Bioactive Chewables stand out as a game-changing solution. These delicious chewables have been meticulously formulated to provide not just a tasty treat, but a powerful tool for those seeking to control their calorie consumption without sacrificing flavor or satisfaction. This all-natural product is manufactured by Avesta Good Earth Foods, a part of Avesthagen.
Teestar® is developed from an Indian medicinal plant commonly used as a part of the food matrix. It has been used in traditional medicine as a potent sugar and calorie modulator and also to manage healthy body mass. It is recommended to have two chewables before breakfast and dinner daily for best results.
Whether you’re at work, in the gym, or on a weekend adventure, Teestar® Bioactive Chewables are your convenient companion for sugar and weight management. They’re easy to carry and provide a guilt-free option wherever life leads you.
Teestar Bioactive Chewables are a taste sensation. Indulge your sweet tooth with flavours that will tantalize your taste buds, all while staying on track with your calorie goals and managing your sugar levels. Whether you’re an athlete, a fitness enthusiast, or just someone looking to maintain a healthy lifestyle, these chewables have you covered.
Avesthagen’s dedication to scientific excellence is reflected in Teestar Bioactive Chewables. Their team of experts has carefully developed these chewables to provide a delicious and effective way to manage sugar and weight, making healthy living more accessible to all.
Avesthagen Limited is an international, integrated, diversified life sciences company based on a systems-biology approach. The company is at the forefront of the convergence of food, pharma, and population genetics for developing new products and novel therapies. Avesthagen aims to commercialize its developed products and technologies geared towards Nutrigenomics, Agriculture, and Precision Medicine with its proprietary Predictive, Preventive and Personalized (“PPP”) healthcare platform.
If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.